Latest News

Nicoli’s lab discovered mRNA that changes how proteins behave. Now she wants to turn it into medicine, starting with diseases of the blood vessels.

Hattie Chung, PhD, assistant professor of medicine (cardiology) and of molecular, cellular, and developmental biology, received a Chan Zuckerberg BioHub New York Investigator Program grant and is now part of their “investigator network."

Research core facilities offer access to expertise and advanced equipment—and they empower scientists to focus on the big-picture questions in their fields.

A new experimental vaccine is showing incredible potential as a treatment option for melanoma, one of the most dangerous types of skin cancer. Compared to other types of skin cancer, melanoma is much more likely to spread to other parts of the body if not found and treated early. Even when it is surgically removed, melanoma can return, or recur.

Adults at high risk of melanoma recurrence and spread were able to stay cancer-free with personalized vaccines made with mRNA technology.

The Yale labs of Anna Marie Pyle and Craig Wilen have developed a norovirus vaccine, effective in mouse models, that portends a new approach to vaccine development for emerging RNA viruses.

Every time a cell divides, it shuts off its own transcription machinery. Researchers have discovered a surprising part of that process that may open a new door for cancer therapy.

A first-of-its-kind 3D genome atlas of human tonsil tissue leads to new discoveries in antibody production and beyond.

Amos Espinosa, a PhD candidate in the Krause Laboratory and a medical research scholar in the Yale Combined Program in the Biological and Biomedical Sciences, has been awarded an F31 NRSA Fellowship from the National Cancer Institute